Landlocked developing countries (LLDCs) vs Nigeria: Percentage of bloodstream infection due to methicillin-resistant
Landlocked developing countries (LLDCs)
53.8%
in 2022
Nigeria
65.1%
in 2022
Landlocked developing countries (LLDCs) rank
3rd
Nigeria rank
4th
Percentage of bloodstream infection due to methicillin-resistant over time
- Landlocked developing countries (LLDCs)
- Nigeria
How they compare
Nigeria currently reports 65.1% against 53.8% in Landlocked developing countries (LLDCs), a difference of 11.3%.
That makes Nigeria's figure about 1.2 times Landlocked developing countries (LLDCs)'s.
Across all 5 years both countries report, Nigeria has been ahead every year.
Landlocked developing countries (LLDCs) ranks 3rd and Nigeria ranks 4th of 4 regions.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.8% | 64.3% | 41.5% | Nigeria |
| 2020s | 62.2% | 69.1% | 6.8% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Landlocked developing countries (LLDCs) or Nigeria?
- Nigeria, at 65.1% against 53.8% in Landlocked developing countries (LLDCs) as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Landlocked developing countries (LLDCs) and Nigeria?
- 11.3%, with Nigeria ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Nigeria?
- 5 years are reported by both, from 2017 to 2022.
- How do Landlocked developing countries (LLDCs) and Nigeria rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Landlocked developing countries (LLDCs) ranks 3rd and Nigeria ranks 4th of 4 regions.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.